Skip to main content
SpringerLink
Log in

Dreißig Jahre Defibrillatortherapie in Deutschland (1984–2014)

Indikationen – Ergebnisse – Perspektiven

Thirty years of defibrillator therapy in Germany (1984–2014)

Indications, results and perspectives

  • Diagnostische Elektrophysiologie und Devices
  • Published:
Der Kardiologe Aims and scope

Zusammenfassung

Der implantierbare automatische Kardioverter-Defibrillator (ICD) wurde 1980 erstmals bei einem Menschen in Baltimore/USA implantiert. In Deutschland wurden die ersten ICD-Implantationen im Januar 1984 in Düsseldorf und Hannover durchgeführt. Der plötzliche Herztod (PHT) gehört zu den häufigsten Todesursachen in der westlichen Welt, und jährlich erliegen in Deutschland etwa 70.000 bis 100.000 Menschen einem PHT, in den USA versterben etwa 450.000 Menschen plötzlich und unerwartet. Auch 34 Jahre nach der Erstimplantation in den USA und 30 Jahre nach den ersten Implantationen in Deutschland ist der ICD ist die beste Therapie der Wahl zur Primär- und Sekundärprophylaxe zur Verhinderung eines PHT und ist allen anderen therapeutischen Konzepten eindeutig überlegen. Die kardiale Resynchronisationstherapie (CRT) ist eine wesentliche Erweiterung der ICD-Therapie und führt nicht nur zu einer Herzinsuffizienz-, sondern auch zu einer Prognoseverbesserung.

Abstract

An automatic cardioverter defibrillator (ICD) was implanted for the first time in a human in Baltimore USA in 1980. The first ICD implants were performed in Germany in January 1984 in Düsseldorf and Hannover. Sudden cardiac death (SCD) is one of the major problems in the western world with approximately 70,000–100,000 SCD patients in Germany and 450,000 in the USA. Currently, 34 years after the first implant in USA and 30 years after the first implants in Germany, the ICD is the method of choice for primary or secondary prevention of SCD and is superior to all other therapeutic approaches. Cardiac resynchronization therapy (CRT) is an important additional therapeutic tool and leads to improvements in congestive heart failure and overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8

Literatur

  1. Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853

    Article  PubMed  Google Scholar 

  2. Arntz HR, Klein HH, Trappe HJ, Andresen D (2011) Kommentar zu den Leitlinien 2010 des European Resuscitation Council (ERC) zur kardiopulmonalen Reanimation (CPR) des Erwachsenen und Notfallversorgung von Patienten mit akutem Koronarsyndrom. Kardiologe 5:162–165

    Article  Google Scholar 

  3. Auricchio A, Fantoni C, Regoli F et al (2004) Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 109:1133–1139

    Article  PubMed  Google Scholar 

  4. Auricchio A, Stellbrink C, Sack S et al (2002) Chronic effect of hemodynamically optimized cardiac resynchronization therapy on patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026–2033

    Article  PubMed  Google Scholar 

  5. Bain AC, Swerdlow CD, Love CJ et al (2001) Multicenter study of principles-based waveforms for external defibrillation. Ann Emerg Med 37:5–12

    Article  PubMed  CAS  Google Scholar 

  6. Bänsch D, Antz M, Boczor S (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105:1453–1458

    Article  PubMed  Google Scholar 

  7. Bardy GH, Lee KL, Mark DB (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  PubMed  CAS  Google Scholar 

  8. Bardy GH, Smith WM, Hood MA (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363:36–44

    Article  PubMed  CAS  Google Scholar 

  9. Beck CS, Pritchard WH, Feil HS (1947) Ventricular fibrillation of long duration abolished by electric shock. J Am Med Assoc 135:985–986

    Article  PubMed  CAS  Google Scholar 

  10. Blanchard SM, Knisley SB, Walcott GP, Ideker RE (1994) Defibrillation waveforms. In: Singer I (Hrsg) Implantable cardioverter defibrillator. Futura Publishing Company, New York, S 153–178

  11. Bristow M, Saxon L, Boehmer J et al (2004) Cardiac resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150

    Article  PubMed  CAS  Google Scholar 

  12. Carlsson J, Erdogan A, Neuzner J (2013) Defibrillator. In: Fröhlig G, Carlsson J, Jung J et al (Hrsg) Herzschrittmacher- und Defibrillator-Therapie. Thieme, Stuttgart, S 198–211

  13. Carlsson J (2013) Indikationen zur Defibrillatortherapie. In: Fröhlig G, Carlsson J, Jung J et al (Hrsg) Herzschrittmacher- und Defibrillator-Therapie. Thieme, Stuttgart, S 153–182

  14. Cazeau S, Leclerq C, Lavergne T et al (2001) Multisite stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880

    Article  PubMed  CAS  Google Scholar 

  15. Christ M, Bracht M van, Prull MW, Trappe HJ (2012) Einflüsse medizinischer Aufklärungsarbeit auf Erste-Hilfe und AED-Kenntnisse in der Allgemeinbevölkerung: 10 Jahre LAGO – die Therme Herne. Dtsch Med Wochenschr 137:2251–2255

    Article  PubMed  CAS  Google Scholar 

  16. Chung MK, Szymkiewicz SJ, Shao M (2010) Aggregate national experience with the wearable cardioverter-defibrillator. Event rates, compliance, and survival. J Am Coll Cardiol 56:194–203

    Article  PubMed Central  PubMed  Google Scholar 

  17. Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549

    Article  PubMed  CAS  Google Scholar 

  18. Conolly SJ, Gent M, Roberts S et al (2000) Canadian implantable defibrillator study (CIDS): a randomised trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302

    Article  Google Scholar 

  19. Curtis AB, Ellenbogen KA, Hammill SC et al (2004) Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 1:371–375

    Article  PubMed  Google Scholar 

  20. Dickstein K, Vardas PE (2010) 2010 focused update of ESC guidelines on device therapy in heart failure. Eur Heart J 31:2677–2687

    Article  PubMed  Google Scholar 

  21. Epstein AE, DiMarco JP, Ellenbogen KA (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 51:e1–e62

    Article  PubMed  Google Scholar 

  22. Ezekowitz JA, Armstrong PW, McAllister FA (2003) Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomised, controlled trials. Ann Intern Med 138:445–452

    Article  PubMed  Google Scholar 

  23. Fröhlig G (2013) Sonden. In: Fröhlig G, Carlsson J, Jung J et al (Hrsg) Herzschrittmacher- und Defibrillator-Therapie. Thieme, Stuttgart, S 255–274

  24. Gliner BE, Jorgenson DB, Poole JE (1998) Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillator. IEEE Biomed Intrum Technol 32:631–644

    CAS  Google Scholar 

  25. Hohnloser SH, Kuck KH, Dorian P et al (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351:2481–2488

    Article  PubMed  CAS  Google Scholar 

  26. Julian DG, Camm AJ, Frangin G et al (1997) Randomised trial of the effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction. EMIAT. Lancet 349:667–674

    Article  PubMed  CAS  Google Scholar 

  27. Jung W, Andresesen D, Block M et al (2005) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95:696–708

    Article  Google Scholar 

  28. Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 351:2151–2158

    Article  Google Scholar 

  29. Kitamura T, Iwami T, Kawamura T et al (2010) Nationwide public-access defibrillation in Japan. N Engl J Med 362:994–1004

    Article  PubMed  CAS  Google Scholar 

  30. Klein H (2006) Prävention des plötzlichen Herztodes. Internist (Berl) 47:1040–1050

  31. Kuck KH, Cappato R, Siebels J et al (2000) Randomised comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754

    Article  PubMed  CAS  Google Scholar 

  32. Lemke B, Israel CW (2013) Kardiale Resynchronisation. In: Fröhlig G, Carlsson J, Jung J et al (Hrsg) Herzschrittmacher- und Defibrillator-Therapie. Thieme, Stuttgart, S 138–152

  33. Markewitz A (2013) Implantation von Herzschrittmachern und implantierbaren Cardioverter-Defibrillatoren. In: Fröhlig G, Carlsson J, Jung J et al (Hrsg) Herzschrittmacher- und Defibrillator-Therapie. Thieme, Stuttgart, S 275–321

  34. Mirowski M, Reid PR, Mower MM (1980) Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 303:322–324

    Article  PubMed  CAS  Google Scholar 

  35. Mirowski M, Mower MM, Staewen WS et al (1970) Standby automatic defibrillator: an approach to prevention of sudden coronary death. Arch Intern Med 126:158–161

    Article  PubMed  CAS  Google Scholar 

  36. Moss AJ, Hall WJ, Cannom DS et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940

    Article  PubMed  CAS  Google Scholar 

  37. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  38. Neuzner J (2013) Das elektrische Implantat als klinisch-diagnostisches System. In: Fröhlig G, Carlsson J, Jung J et al (Hrsg) Herzschrittmacher- und Defibrillator-Therapie. Thieme, Stuttgart, S 586–595

  39. Nisam S, Mower MM, Moser S (1991) ICD clinical update: first decade, initial 10000 patients. Pacing Clin Electrophysiol 14:255–262

    Article  PubMed  CAS  Google Scholar 

  40. Saxon LA, Hayes DL, Day J et al (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 122:2359–2367

    Article  PubMed  Google Scholar 

  41. Schneider T, Martens PR, Paschen H et al (2000) Multicenter, randomized, controlled trial of 150-J biphasic compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation 102:1780–1787

    Article  PubMed  CAS  Google Scholar 

  42. Senges-Becker JC, Klostermann M, Becker R et al (2005) What is the „optimal“ follow-up schedule for ICD patients? Europace 7:319–326

    Article  PubMed  Google Scholar 

  43. Stellbrink C, Auricchio A, Lemke B et al (2003) Positionspaper zur kardialen Resynchronisationstherapie. Z Kardiol 92:96–103

    Article  PubMed  CAS  Google Scholar 

  44. Strickberger SA, Hummel JD, Bartlett TG (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J Am Coll Cardiol 41:1707–1712

    Article  PubMed  Google Scholar 

  45. The DAVID Trial Investigators (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 25:3115–3123

    Google Scholar 

  46. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmia. N Engl J Med 337:1576–1583

    Article  Google Scholar 

  47. Trappe HJ (2009) Prä- oder intrahospitaler Herz-Kreislauf-Stillstand. Häufigkeit, Ergebnisse, Perspektiven. Kardiologe 3:37–46

    Article  Google Scholar 

  48. Trappe HJ (2007) Plötzlicher Herztod. Häufigkeit, Risikoidentifikation, Behandlungsstrategien. Kardiologe 1:261–271

    Article  Google Scholar 

  49. Trappe HJ (2008) Kardiale Resynchronisationstherapie. Voraussetzungen, Ergebnisse, Perspektiven. Kardiologe 2:407–416

    Article  Google Scholar 

  50. Trappe HJ (2009) Brugada-Syndrom: Definition, Diagnostik, Therapie, Prognose. Kardiologe 3:309–318

    Article  CAS  Google Scholar 

  51. Trappe HJ (2014) Tachykarde Herzrhythmusstörungen. In: Leuwer M, Marx G, Trappe HJ, Zuzan O (Hrsg) Checkliste Intensivmedizin, 4. Aufl. Thieme, Stuttgart, S 385–394

  52. Trappe HJ (2012) Automated external defibrillators: what’s established? What’s new? Appl Cardiopulm Pathophysiol 16:162–173

    Google Scholar 

  53. Trappe HJ, Gummert J (2011) Aktuelle Schrittmacher- und Defibrillatortherapie. Indikationen, Problemfelder und Entwicklungen der letzten Jahre. Dtsch Ärztebl Int 108:372–380

    PubMed Central  PubMed  Google Scholar 

  54. Trappe HJ, Arntz HR (2011) Lebensbedrohliche Herzrhythmusstörungen. Notfall Rettungsmed 14:93–94

    Article  Google Scholar 

  55. Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 28:2256–2295

    Article  PubMed  Google Scholar 

  56. Walcott GP, Rollins DL, Smith WM, Ideker R (1996) Effect of changing capacitors between phases of a biphasic defibrillation shock. Pacing Clin Electrophysiol 19:945–954

    Article  PubMed  CAS  Google Scholar 

  57. Wellens HJJ (2012) Sudden cardiac arrest – How can we improve results of resuscitation? Appl Cardiopulm Pathophysiol 16:127–132

    Google Scholar 

  58. Wilkoff BL, Kudenchuk PJ, Buxton AE et al (2009) The DAVID (Dual chamber and VVI implantable defibrillator) II trial. J Am Coll Cardiol 53:872–880

    Article  PubMed  Google Scholar 

  59. Winkle RA, Mead RH, Ruder MA (1989) Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 13:1353–1361

    Article  PubMed  CAS  Google Scholar 

  60. Zipes DP, Camm J, Borggrefe M (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 48:e247–e346

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. H.-J. Trappe gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Medizinische Universitätsklinik II (Schwerpunkte Kardiologie und Angiologie), Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland

    H.-J. Trappe

Authors
  1. H.-J. Trappe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H.-J. Trappe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trappe, HJ. Dreißig Jahre Defibrillatortherapie in Deutschland (1984–2014). Kardiologe 8, 125–137 (2014). https://doi.org/10.1007/s12181-014-0565-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0565-0

Schlüsselwörter

Keywords

Search

Navigation